SUMMARY The distribution of the subtypes 'ay' and 'ad' has been assessed in 159 hepatitis B antigen (HB-Ag) positive subjects with a variety of associated hepatic conditions. A specific subtype could not be correlated with any particular hepatic pathology when the whole group was considered. However, the distribution of these two subtypes did vary according to the geographical origin of the subject or infection, or the presumed route of infection, so that there was an apparent association of one subtype with a certain disease state. Subtyping performed on 10 HB-Ag-positive households showed the subtype to be the same within nine, emphasizing the epidemiological rather than the pathological importance of the 'ay' and 'ad' subtypes of the HB-Ag.
It is now well established that various subtypes of the HB-Ag exist. Most HB-Ag positive sera contain a common antigenic determinant 'a'. Le Bouvier (1971) has described two mutually exclusive subtypes 'y' and 'd', which appear to be viral in origin. Several authors have commented upon the distribution of the 'ay' and 'ad' subtypes amongst the various hepatic conditions associated with the HB-Ag, some reporting association of a specific subtype with certain disease states (Nielsen and Le Bouvier, 1973) , although others have noted a scattering of subtypes throughout the spectrum of liver diseases (Holland, Purcell, Smith, and Alter, 1972; Gordon, Berberian, Stevenson, and Redeker, 1972) .
We have assessed the distribution of subtypes 'ay'
and 'ad' amongst our HB-Ag positive subjects to determine whether these two subtypes are of pathological or epidemiological importance.
Patients Studied DIAGNOSTIC GROUPS
A total of 159 HB-Ag positive subjects have been studied. Sixty-nine patients were diagnosed as having acute hepatitis on a clinical and biochemical basis. Seventeen subjects were thought to be healthy carriers of the HB-Ag, as they were persistently HB-Ag positive for six months or more without any clinical or biochemical evidence of liver disease. Forty-one patients had biopsy-proven chronic aggressive hepatitis, many of whom had superimposed cirrhosis. Another 27 patients with chronic persistent hepatitis were studied. However, three of (Gordon et al, 1972) .
All serum samples were set up against 'y' and 'd' antisera and tested by counterimmunoelectrophoresis, as described by Holland et al (1972 It can be seen from table I that patients with chronic aggressive hepatitis were commonly 'ay' in type. Although even when this group of patients were compared with all the other HB-Ag-positive subjects, there was still no significant difference in the distribution of the two subtypes. But further analysis of these 41 patients with chronic aggressive hepatitis showed 27 to be Mediterranean in origin.
We have therefore compared the subtype findings in the Mediterranean subjects with those from the other large geographical group, ie, northern Europeans. The ratio 'ay' to 'ad' was found to be significantly greater in the Mediterraneans (2 x 2 x2 test: p < 0005) ( Differences in the distribution of the two subtypes were also seen when the results for each diagnostic group (acute hepatitis, chronic persistent hepatitis, chronic aggressive hepatitis, and carriers) from northern Europe and the Mediterranean were compared.
The two subtypes were nearly equally distributed amongst the patients with acute hepatitis from these two geographical areas (table III) . However, if these patients are further subdivided where possible, into where and how they were thought to have contracted hepatitis, a difference in distribution of the two subtypes is seen.
Amongst the 51 northern Europeans with acute hepatitis, information regarding recent travel abroad was not obtained from 12. Of the remaining 39
The epidemiological importance of 'ay' and 'ad' subtypes of the HB-Ag When the results from the patients with chronic persistent hepatitis from these two geographical areas were considered, there was no significant difference in the distribution of 'ay' and 'ad' subtypes.
However, the ratio 'ay' to 'ad' was found to be significantly greater in our Mediterranean than our northern European patients with chronic aggressive hepatitis (2 x 2 x2 test: P < 005).
Amongst the healthy carriers from these two geographical areas the ratio 'ay' to 'ad' was found to be significantly lower in the northern Europeans (Fisher's exact method P = 0.041).
The subtyping results from the HB-Ag-positive subjects from the Middle East and from those placed in the miscellaneous group have not been included in this statistical analysis as the numbers were so small. All but one of the eight patients from the Middle East (one acutehepatitis, two chronic aggressive hepatitis, two chronic persistent hepatitis, one carrier, and two primary liver cell cancers) were 'ay' in type. Similarly, the 'ay' subtype predominated amongst the 16 HB-Ag-positive subjects placed in the miscellaneous group (11/16 'ay').
The results from the nine households where intrahousehold, non-parenteral transmission of the HBAg was suspected showed the subtype to be the same within each household. Five households were all 'ay' and four all 'ad' in type. In the tenth household where a male homosexual, who presented with acute hepatitis, was found to be living in the same house as a healthy carrier of the HB-Ag, but denied sexual contact with the carrier, the subtypes were different.
Discussion
Our results demonstrate that both subtypes 'ay' and 'ad' may be associated with all forms of HB-Agpositive acute and chronic liver disease and in healthy carriers. However, the geographical origin of the HB-Ag-positive person, and possibly the route of infection with the HB-Ag may influence the subtype findings in any one area.
Although our figures suggest that subtype 'ay' is associated with chronic aggressive hepatitis in our Mediterranean patients, this same subtype was also seen more commonly amongst those Mediterranean patients with acute hepatitis who either acquired the infection in their country of origin or from other Mediterranean subjects living in Great Britain. This predominance of the 'ay' subtype was also seen amongst the HB-Ag-positive subjects with chronic persistent hepatitis and the healthy carriers from the Mediterranean. These findings are in accordance with those of a much larger survey of HB-Ag-positive subjects from Greece (Hadziyannis and Le Bouvier, 1972) .
It would seem that subtype 'ad' predominates in northern Europe. This was clearly seen from the results of subtyping the healthy HB-Ag carriers from this area, and subtype 'ad' also predominated in the other diagnostic groups from northern Europe, apart from those subjects with acute hepatitis. However, if the subtyping results of those with acute hepatitis who gave a history of parenteral exposure were withdrawn, again subtype 'ad' predominated in the northern European subjects.
Other workers have found HB-Ag-positive cirrhosis to be exclusively 'ad' in type (Nielsen and Le Bouvier, 1973) (Iwarson, Magnius, Lindholm, and Lundin, 1973) .
Therefore, it would seem that infection with a particular subtype of the hepatitis B virus is associated with epidemiological factors and cannot be related to any particular form of hepatic pathology.
The concordance of subtyping in our household studies and in those of others (Holland et al, 1972) emphasizes the epidemiological rather than the pathological importance of the 'ay' and 'ad' subtypes. In seven of the studies where non-parenteral, intrhousehold transmission of the hepatitis B virus was suspected, there was no familial relationship between the HB-Ag-positive persons.
In summary, both 'ay' and 'ad' subtypes seem to be distributed throughout the spectrum of liver diseases associated with the HB-Ag. However, a particular subtype may predominate within certain geographical areas at a given time, or when acquired by a particular route of infection, thereby accounting for the apparent association of a specific subtype with a certain disease state.
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